Literature DB >> 1698365

Convulsants induce interleukin-1 beta messenger RNA in rat brain.

M Minami1, Y Kuraishi, T Yamaguchi, S Nakai, Y Hirai, M Satoh.   

Abstract

The effects of systemic administration of kainic acid and pentylenetetrazol on interleukin-1 beta gene expression in the rat brain was studied. After the administration of kainic acid in a convulsive dose (10 mg/kg i.p.), Interleukin-1 beta mRNA was induced intensely in the cerebral cortex, thalamus and hypothalamus, moderately in the hippocampus and weakly in the striatum, but not in the midbrain, pons-medulla and cerebellum. Pentylenetetrazol induced Interleukin-1 beta mRNA in the cerebral cortex, hypothalamus, and hippocampus with a faster time-course than kainic acid. Diazepam suppressed both the convulsion and the induction of Interleukin-1 beta mRNA produced by kainic acid. Dexamethasone suppressed the induction of Interleukin-1 beta mRNA, but did neither the convulsion nor the induction of c-fos mRNA following the injection of kainic acid. These results provide the first evidence that intensive neuronal excitation induces Interleukin-1 beta mRNA in particular regions of the brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698365     DOI: 10.1016/0006-291x(90)91221-d

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

2.  Regulation of brain interleukin-1 beta (IL-1 beta) system mRNAs in response to pathophysiological concentrations of IL-1 beta in the cerebrospinal fluid.

Authors:  S E Ilyin; G Sonti; D Gayle; C R Plata-Salamán
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

3.  The cortical innate immune response increases local neuronal excitability leading to seizures.

Authors:  Krista M Rodgers; Mark R Hutchinson; Alexis Northcutt; Steven F Maier; Linda R Watkins; Daniel S Barth
Journal:  Brain       Date:  2009-06-30       Impact factor: 13.501

Review 4.  Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad.

Authors:  Mandakh Bekhbat; Sydney A Rowson; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2017-05-11       Impact factor: 8.606

5.  Anti-inflammatory efficacy of dexamethasone and Nrf2 activators in the CNS using brain slices as a model of acute injury.

Authors:  David J Graber; William F Hickey; Elijah W Stommel; Brent T Harris
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-17       Impact factor: 4.147

6.  [Interleukin-1 receptors in the central nervous system: role in infection and in stress].

Authors:  F Haour; C Marquette; E Ban; M Crumeyrolle-Arias; G Fillion
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

7.  Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response.

Authors:  S Rivera; E Tremblay; S Timsit; O Canals; Y Ben-Ari; M Khrestchatisky
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

8.  HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death.

Authors:  M T Corasaniti; A Bilotta; M C Strongoli; M Navarra; G Bagetta; G Di Renzo
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

9.  Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells.

Authors:  K Alheim; C Andersson; S Tingsborg; M Ziolkowska; M Schultzberg; T Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

10.  Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.

Authors:  A Vezzani; M Conti; A De Luigi; T Ravizza; D Moneta; F Marchesi; M G De Simoni
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.